Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB06699"
| Predicate | Value (sorted: default) |
|---|---|
| rdfs:label |
"Degarelix"
|
| rdf:type | |
| ns1:description |
"Degarelix is used for the treatment of advanced prostate cancer. Degarelix is a synthetic peptide derivative drug which binds to gonadotropin-releasing hormone (GnRH) receptors in the pituitary gland and blocks interaction with GnRH. This antagonism reduces luteinising hormone (LH) and follicle-stimulating hormone (FSH) which ultimately causes testosterone suppression. Reduction in testosterone is important in treating men with advanced prostate cancer. Chemically, it is a synthetic linear decapeptide amide with seven unnatural amino acids, five of which are D-amino acids. FDA approved on December 24, 2008. "
|
| ns1:drugCategory | |
| ns1:interactsWith | |
| owl:sameAs |
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/drugbank_small.nt
The resource appears as object in 4 triples